DuPont de Nemours, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $6.8B | $6.7B | $6.6B | $13.0B | $12.6B |
| Cost of revenue | $4.5B | $4.5B | $4.4B | $8.4B | $8.0B |
| Selling, general & administrative | $1.0B | $976.0M | $891.0M | $1.5B | $1.6B |
| Research and development | $193.0M | $203.0M | $192.0M | $536.0M | $557.0M |
| Interest expense | $313.0M | $366.0M | $396.0M | $492.0M | $525.0M |
| Pretax income | $200.0M | $117.0M | -$279.0M | $1.4B | $1.4B |
| Income tax expense | $102.0M | $213.0M | -$217.0M | $387.0M | $237.0M |
| Net income | -$779.0M | $703.0M | $423.0M | $5.9B | $6.5B |
| Balance Sheet | |||||
| Cash and equivalents | $715.0M | $1.8B | $2.4B | $3.7B | $2.0B |
| Current assets | $5.6B | $20.8B | $7.5B | $11.3B | $14.3B |
| Total assets | $21.6B | $36.6B | $38.6B | $41.4B | $45.7B |
| Current liabilities | $2.3B | $5.5B | $3.1B | $3.7B | $4.9B |
| Total liabilities | $7.5B | $12.8B | $13.8B | $14.3B | $18.7B |
| Stockholders' equity | $13.9B | $23.4B | $24.3B | $26.6B | $26.4B |
| Cash Flow Statement | |||||
| Cash from operations | $560.0M | $765.0M | $845.0M | $588.0M | $2.3B |
| Depreciation and amortization | $647.0M | $635.0M | $580.0M | $1.1B | $1.1B |
| Stock-based compensation | $38.0M | $56.0M | $57.0M | $75.0M | $67.0M |
| Capital expenditure | $333.0M | $285.0M | $302.0M | $662.0M | $788.0M |
| Free cash flow | $227.0M | $480.0M | $543.0M | -$74.0M | $1.5B |
| Dividends paid | $597.0M | $635.0M | $651.0M | $652.0M | $630.0M |
| Share repurchases | — | — | — | — | $2.1B |
| Impairments | $0 | $0 | $668.0M | $94.0M | $0 |
Shares outstanding 409.9M · Free float 99.6%
Annual filing data through FY ended December 31, 2025; float as of July 14, 2026.